Cedelizumab
id:
cedelizumab-263-7380243
title:
Cedelizumab
text:
Cedelizumab is a monoclonal antibody acting on the immune system. Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases. It has been approved by both the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of patients with moderate-to-severe Crohn's disease (CD) and ulcerative colitis (UC). Vedolizumab is a humanized monoclonal antibody, which binds to integrin α4β7 on T lymphocytes to interfere with
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Cedelizumab
date created:
date modified:
2023-05-30T01:34:56Z
main entity:
{"identifier":"Q5057039","url":"https://www.wikidata.org/entity/Q5057039"}
image:
fields total:
13
integrity:
14